Cocrystal Pharma, Inc. (COCP) Form 8-K Material Events
Cocrystal Pharma, Inc. (COCP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: COCP
CIK: 1412486
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Weinberg & Company, P.A.
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerJohn Lucas
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001493152-26-041877 | View SEC Doc Filr Page |
| 3 | 2026-08-21 | 2026-08-12 | 3 | 0001493152-26-039674 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-12 | 8-K | 0001493152-26-039023 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-17 | 8-K | 0001493152-26-038747 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037573 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-07 | — | SCHEDULE 13D Filing | 0000944809-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-07 | — | SCHEDULE 13D/A Filing | 0001493152-26-036650 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-05 | 4 | 0001493152-26-036396 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 | 0001493152-26-036169 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-07-31 | 8-K | 0001493152-26-035743 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-14 | 8-K | 0001493152-26-033662 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-03 | 8-K | 0001493152-26-027837 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-03 | 4 | 0001493152-26-027054 | View SEC Doc Filr Page |
| 3 | 2026-06-03 | 2026-06-03 | 3 | 0001493152-26-027053 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | 8-K | 0001493152-26-026965 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-27 | — | DEFA14A | 0001493152-26-025430 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-27 | 2026-05-27 | DEF 14A | 0001493152-26-025428 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-26 | 8-K | 0001493152-26-025172 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023377 | View SEC Doc Filr Page |
| EFFECT | 2026-05-01 | — | EFFECT Filing | 9999999995-26-001445 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0001493152-26-020586 | View SEC Doc Filr Page |
| CORRESP | 2026-04-29 | — | CORRESP Filing | 0001493152-26-019607 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-28 | — | UPLOAD Filing | 0000000000-26-004357 | View SEC Doc Filr Page |
| S-3 | 2026-04-23 | — | S-3 | 0001493152-26-018732 | View SEC Doc Filr Page |
| 8-K | 2026-04-02 | 2026-04-02 | 8-K | 0001493152-26-014819 | View SEC Doc Filr Page |